SG Americas Securities’s Gossamer Bio GOSS Stock Holding History
Bought
Maintained
Sold
Other funds holding GOSS
6CM
DIG
CCM
WVP
GCP
WAM
KCM
SG Americas Securities's GOSS Position: Q2 2026 in Review
SG Americas Securities increased its Gossamer Bio (GOSS) stake by 14% in Q2 2026, buying an estimated $5.07K and bringing the position to 146,737 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #3257.
SG Americas Securities first reported a position in GOSS in Q2 2020 and has held it in 14 quarters since. The position peaked at $714K in Q2 2020. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.
- SG Americas Securities held 146,737 shares of Gossamer Bio worth $24K as of Q2 2026.
- SG Americas Securities bought 18,169 Gossamer Bio shares in Q2 2026, an estimated $5.07K.
- Gossamer Bio made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #3257 holding.
- SG Americas Securities first reported a position in Gossamer Bio in Q2 2020 and has held it in 14 quarters since.
- SG Americas Securities's Gossamer Bio position peaked at $714K in Q2 2020.
- 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.